Country Profile

Slovakia

Slovakia is a developing market for Indian pharmaceuticals — $4.14M in FY 2025–26. Medicine Ingredients accounts for 54% of shipments.

🇸🇰 $4.14M · 0.6× growth since FY2016
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$4.14M
Exports FY2025–26 DGCIS
0.6×
Growth FY2016→2026
54%
Medicine Ingredients Share
4
Product Categories Supplied
6
Years of Trade Data
Slovakia is a developing market for Indian pharmaceuticals — $4.14M in FY 2025–26. Medicine Ingredients accounts for 54% of shipments.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $2.23M (53.7%) Medicines $802K (19.4%) Traditional & Herbal $696K (16.8%) Surgical & Hospital Supplies $419K (10.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Slovakia in the RBI overseas direct investment dataset (2011–2026).